Chemed Reports Third-Quarter 2021 Results - Full-Year 2021 Earnings Guidance Increased
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Chemed Corporation (CHE) Tops Q3 EPS by 54c
October 28, 2021 4:20 PM EDTChemed Corporation (NYSE: CHE) reported Q3 EPS of $5.06, $0.54 better than the analyst estimate of $4.52. Revenue for the quarter came in at $539 million versus the consensus estimate of $531.87 million.
GUIDANCE:
Chemed Corporation sees FY2021 EPS of $17.00-$17.50, versus the consensus of... More



